BPC-157 is on the World Anti-Doping Agency (WADA) Prohibited List under category S0 (non-approved substances)
In-vitro assays show the molecule is membrane-permeable, which supports the possibility of oral absorption, but the animal efficacy studies used injection, and no study has directly compared oral versus subcutaneous bioavailability
Floating Particles: This is an obvious sign of contamination
B., Yang, B., SenGupta, T., Caponio, D., Khezri, R., Demarest, T
Research indicates BPC-157 significantly enhances cell survival under oxidative stress conditions (H2O2 exposure), protecting fibroblasts during the inflammatory phase of healing when reactive oxygen species are elevated
In 3T3-L1 adipocyte cultures, 5-Amino-1MQ treatment reduced adipocyte size by approximately 40%, decreased expression of lipogenic genes DGAT1 and DGAT2 (diacylglycerol acyltransferases responsible for triglyceride synthesis), and reduced total lipid accumulation